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Microscopy, Mass cytometry, CytokineCancer Research, London, UK) asked this question with
respect to cell shape and its impact on cell signaling.Over 250 scientists converged upon Harvard Medical
School for the seventh annual International Conference
on Systems Biology of Human Disease (SBHD). Originally
conceived by the systems-biology working groups of
Boston and Heidelberg, the SBHD has grown to become
an important venue for disease-relevant research at the
systems level. The modest size of SBHD hits that conference
sweet spot, where you can still make five or six new friends
while touching base with 15 or so old ones.
SBHD dedicates itself to systems biology, a field that is
in its teenage years as a discipline. Like most teenagers,
systems biology no longer yearns for the approval of its
parents (molecular biology and mathematics), even
though it cannot possibly succeed on its own without
them. We get caught up as a group in the latest fashions
(cellular heterogeneity), whereas others fall out of style
(interaction hairballs). Fortunately, the upbringing of
the systems-biology community has been healthy so
far - cliquishness is at a minimum, and good science
is at the forefront. During the meeting, we heard
from cell biologists, engineers, geneticists, theoreticians,
technologists and bioinformaticians, who all connected
with systems biology in various ways. There were also
multiple invited talks on microbiology, an area that has
been somewhat slower to adopt systems approaches
outside of model organisms.* Correspondence: kjanes@virginia.edu
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Heterogeneity pervaded the meeting so much that
SBHD could have stood for ‘single-cell biology and hu-
man disease’. Appreciating cell-to-cell heterogeneity is
pretty straightforward - just look at cells with a microscope
and you will see that no two are identical. But, do we know
how different they truly are? Chris Bakal (Institute of
Focusing on signaling through nuclear factor-κB (NF-κB),
Bakal found that the strongest responders in a population
exhibited unique nuclear-shape characteristics compared
with those of the average. Cell density played an important
role, as cells at the leading front of a collectively migrating
sheet showed preferential NF-κB activation in response to
tumor necrosis factor. A more complete inventory of
shape-sensitive pathways would be valuable for interpreting
high-content imaging screens with such information
already embedded.
Equally striking were the live-cell examples of cell-to-cell
heterogeneity. Using modern Förster resonance energy
transfer (FRET) reporters of extracellular signal-regulated
kinase (ERK) and 5'-AMP-activated protein kinase (AMPK)
activity, John Albeck (University of California Davis, USA)
showed time-lapse videos of how the single-cell response to
environmental stimuli can differ qualitatively from the
population average. Pulses of activity were observed
over many hours, with time-dependent characteristics
that depended on the sensor and the perturbation.
Understanding how cells interpret these pulses will require
computational models that combine data on signaling,
gene expression and post-translational modifications of
immediate-early gene products.
FRET-based indicators of kinase activity can be problem-
atic for multi-color applications and for kinases with rapid
deactivation kinetics. To address these limitations, Sabrina
Spencer (University of Colorado Boulder, USA) and Markus
Covert (Stanford University, USA) presented independent
designs of one-color sensors that report kinase activity by
localization. The trick is to engineer substrates within atral Ltd. The licensee has exclusive rights to distribute this article, in any
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phosphorylation disrupts the more-potent sequence and
causes relocalization of the reporter. Spencer designed a
reporter for cyclin-dependent kinase 2 in order to investi-
gate the cellular decision to proliferate or quiesce, revealing
a new restriction point in G2 phase that had eluded the
‘starve-and-refeed’ experiments of 40 years ago. Covert
expanded the premise of ‘kinase translocation reporters’
(KTRs) more broadly to the mitogen-activated protein
kinases (MAPKs). Covert showed proof-of-concept mul-
tiplexing of one-color KTRs by tracking ERK, c-jun
N-terminal kinase (JNK) and p38 activities concurrently in
single cells. KTRs showed better reversibility than standard
FRET reporters, suggesting that they could become the
sensor of choice for pathways that are rapidly deactivated.
Bernd Bodenmiller (University of Zürich, Switzerland)
took deep analysis of static images to the next level with
imaging mass cytometry. In Bodenmiller’s setup, tissue
sections are immunostained with heavy metals and then
raster ablated with a UV laser before detection of the
released metals by mass spectrometry. Work in progress
seeks to identify intermediate states during the epithelial-
to-mesenchymal transition of mammary cancer cells. The
sensitivity of imaging mass cytometry should improve
substantially as the technology matures.
Immune cells and cytokine signaling
Another recurring theme at SBHD 2014 was systems
analysis of the immune system and circulating cytokines.
We crossed over from epithelial to immunological
heterogeneity with talks from Kathryn Miller-Jensen
(Yale University, USA) and Grégoire Altan-Bonnet
(Memorial Sloan-Kettering Cancer Center, USA)
about single-cell responses of myeloid and lymphoid
effectors. Miller-Jensen reported on the cascade of
paracrine factors triggered by lipopolysaccharides in
monocytes and macrophages. Using nanowell chips to cap-
ture and profile cytokines released from single cells, Miller-
Jensen compared the population-level secretion patterns
with those obtained from individual cells isolated from
the population. Several late-phase cytokines - including
interleukin-6, interleukin-10 and granulocyte-macrophage
colony-stimulating factor - appeared to be emergent
properties of the population that could not be recapitulated
by the aggregate response of individual cells. Although
Miller-Jensen focused on a bacterial stimulus, these results
could be especially relevant to solid tumors and athero-
sclerosis, where macrophage accumulation is recognized.
Altan-Bonnet embraced the intersection of cancer biology
and immunology by investigating the receptor-proximal be-
havior of transformed B cells in chronic lymphocytic
leukemia (B-CLL). Comparing B-CLL tyrosine kinase
signaling with that of B cells from healthy donors, he
reported bimodal and hysteretic responses of B-CLL cellsto inhibition of tyrosine phosphatases. Altan-Bonnet tied
these dynamical-systems properties of B-CLL cells to
aberrant B-cell receptor clustering, which gives rise to
cooperativity and a saddle-node bifurcation of the
network. This mechanism provides a potential explanation
for why B-CLL cells escape negative selection, and the
bimodality itself could be exploited as a sensitive diagnostic
for staging B-CLL patients.
Of course, good systems biology is still taking place at
the population level for blood cells and their signaling
pathways. Ursula Klingmüller (German Cancer Research
Center, Heidelberg, Germany) examined the potential
dangers of erythropoietin (Epo) therapy for treating anemia
in lung cancer patients undergoing chemotherapy. Certain
non-small cell lung cancers (NSCLCs) can express Epo
receptors at very low levels, causing chemoresistance. By
combining modeling with assay development, Klingmüller
showed that NSCLCs consume Epo even though they may
possess only approximately 50 receptors on their cell
surface. Moreover, she showed that not all Epo variants
were equivalently bioactive towards NSCLCs and erythroid
progenitors, suggesting that some variants might be better
suited for chemotherapy-induced anemia than others.
Cytokine crosstalk was an important motivation for the
systems work on endometriosis presented by Douglas
Lauffenburger (Massachusetts Institute of Technology,
USA). By monitoring the cytokine profiles of aspirates of
peritoneal fluid from women stricken with the disease,
Lauffenburger showed how one could infer the secreting
and receiving cell types that were most consistent with the
observed profiles. This analysis suggested the existence of
macrophage hyperactivity and JNK signaling in endometri-
osis patients with cytokine signatures that correlated to
pain and emphasized the practical constraints that must
be considered when combining systems biology with
clinical material.
Infectious disease
The latest entries into the systems-biology arena at SBHD
2014 involved the bacteriology of infectious disease. Path-
way and network models are a long way off because most
genes lack detailed functional characterization, and it is not
even clear which ones are essential under different condi-
tions. Christopher Sassetti (University of Massachusetts
Medical School, USA) and Tim van Opijnen (Boston
College, USA) tackled this problem for Mycobacterium
tuberculosis and Streptococcus pneumoniae at the gen-
omic level. Using different insertional-mutagenesis and
sequencing-based approaches, Sassetti and van Opijnen
showed how ‘conditional essentiality’, dictated by nutrient
availability and other stresses in the host microenviron-
ment, could be the norm for these infectious agents.
Versatile pathogens have not one network but many
that reconfigure according to the growth conditions.
Janes and Wang Genome Biology 2014, 15:407 Page 3 of 3
http://genomebiology.com/2014/15/1/407A systems-level dissection of the constraints on these
networks might investigate whether bacteria could be
‘trapped’ in certain configurations that eradicate infection.
Concluding remarks
Amidst all the great things brought to SBHD 2014, it
was striking to note what was missing. For example,
aside from our talks and that of Luis Serrano (Center for
Genomic Regulation, Barcelona, Spain), no presentation
showed results with quantitative immunoblots, as if systems
biology had disowned one of its parents. Indeed, Serrano
showed that immunoblots were more robust for absolute
protein quantification than multiple reaction monitoring, a
mass-spectrometry-based approach that is currently in
vogue. Diverse perspectives imply a diversity of methods
that intermingle experimental and computational tech-
niques, both old and new. Like teenagers, we want nothing
but to race around in a fast sports car, forgetting that we
must still use two legs to walk to the driver-side door.
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